FDA and NIH Release Wave 7 PATH Data to Support Tobacco-Related Health Research

Oct.17.2024

FDA and NIH jointly announce the release of the 7th wave of PATH biomarker data file, providing insight on tobacco and health.

According to a recent joint announcement by the U.S. Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIH), the seventh wave of data files for the Population Assessment of Tobacco and Health (PATH) study's biomarker data (BRUF) has been released. This marks the first release of biomarker data collected between January 2022 and April 2023.

According to the official website of the FDA, the PATH (Population Assessment of Tobacco and Health) study is a large-scale, long-term research project on tobacco use and health in the United States. This study is conducted in collaboration with the FDA's Center for Tobacco Products and the National Institute on Drug Abuse Research, began in 2011, and commenced the first round of data collection in 2013.

The primary goal of this study is to help scientists understand the ways and reasons people start smoking, quit smoking, and then start again after quitting by tracking research subjects over the long term. It also aims to investigate the effects of different tobacco products on health, such as cardiovascular and respiratory health. Additionally, the research results may serve as a reference for the FDA to develop actions related to tobacco products, ultimately helping to achieve the goals set out in the Family Smoking Prevention and Tobacco Control Act.

According to the FDA website, researchers can now apply to access these restricted use biological marker data files (BRUF). In addition, the first round of data files has been updated to include samples from adults who have previously experimented with or used any tobacco products. The main linked files for restricted and public use have also been updated to reflect the new files and the current availability of samples in the biological sample acquisition program.

The following is the web address for the seventh wave of biomarker data files on the FDA website:

The provided link leads to the summary of a study available on the ICPSR website.

References:

[1] FDA网站

Also Read:

[1] U.S. FDA and NIH Back Smoking Cessation Innovation, Highlight E-Cigarette Research Needs

[2] Growing Concerns Over Illicit Chinese E-cigarette Sales in America

[3] FDA Seeks Fines for Unauthorized Tobacco Sales from Retailers

[4] Advancing Smoking Cessation: FDA and NIH Priorities

[5] FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers

[6] Boston University Researchers: Majority of E-cigarette Brands Violate FDA Guidelines

[7] FDA Releases Guidance on Tobacco Product Warning Labels and Ads

[8] US House Committee Questions FDA's Focus on E-cigarette Regulation

#North America #United States #Market #Regulation

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | GEEKBAR Launches HOOKAH X on Its Official Website, Featuring Stepless DTL “Infinite Control”

GEEKBAR has launched the disposable hookah-style e-cigarette HOOKAH X on its official website. According to the product page, the device claims to feature “Stepless/Infinite Control,” enabling continuous adjustment across different airflow and draw-resistance ranges. HOOKAH X has also begun selling through online channels in the U.S., with pricing around US$21.99.

Dec.08 by 2FIRSTS.ai

Illegal Vape Suppliers Move Online After Queensland Crackdown

Less than two weeks after Queensland police raided and shut down tobacconists suspected of selling illegal e-cigarettes, at least one supplier has moved its business online. Flyers with QR codes advertising same-day delivery of vapes, tobacco, and nicotine pouches were found taped to electricity poles across the Gold Coast.

Dec.05 by 2FIRSTS.ai

Product | NEXA FLEX Releases “Built in the USA” Version, Says All Flavors Are Tailored for Adult U.S. Users

NEXA has introduced a disposable e-cigarette, NEXA FLEX, which is promoted as “Built in the USA,” highlighting domestic production and flavors developed for adult U.S. vaping consumers. The device retains features such as a transparent e-liquid chamber, Normal/Turbo dual modes, and up to 40,000 puffs, and is scheduled to launch in late November in Texas. Other brands, including SKE and FASTA, have also recently released products labeled as “Made in the USA” or “U.S.-assembled.”

Nov.20 by 2FIRSTS.ai

Product | LOST MARY, ELFBAR & VOZOL Debut 2 mL Replaceable-Pod Devices: Three-Model Comparison

Several brands launch 2 mL replaceable-pod vapes—Lost Mary Glayce, ELFBAR ELFA “Stein,” VOZOL SLEEK—highlighting rechargeability, pod swaps, and a compliance- and sustainability-led trend.